文献速递细菌感染、耐药与抗菌药物

铜绿假单胞菌对头孢洛扎-他唑巴坦耐药复杂通路的基因组流行病学研究

Complex pathways to ceftolozane-tazobactam resistance in clinical Pseudomonas aeruginosa isolates: a genomic epidemiology study.
PubMed 文献 · Clin Microbiol Infect · 2025-09-26

该研究对1682株铜绿假单胞菌(含339株来自澳大利亚Alfred医院及1343株来自六个公共数据集)进行全基因组测序和C/T肉汤微量稀释药敏试验,其中343株(20.4%)为C/T耐药。研究发现耐药涉及ftsI、ampR、ampC等基因的连续突变及两个新基因PA3329和PA4311,ftsI的R504C突变降低头孢洛扎结合亲和力(p 0.016)。

要点

  • 20.4%(343/1682)铜绿假单胞菌临床分离株对C/T耐药,碳青霉烯酶基因检出率12.2%。
  • ftsI、ampR、ampC、PA3329和PA4311与C/T耐药显著相关,其中PA3329和PA4311为新发现基因。
  • ftsI编码的PBP3中R504C突变降低头孢洛扎结合亲和力(p 0.016),连续突变可累加升高MIC。

核心结论

  • 铜绿假单胞菌对C/T耐药存在复杂通路,ftsI可能发挥被低估的作用,并发现两个功能未知的新耐药相关基因。

研究设计与样本

  • 研究纳入1682株铜绿假单胞菌,包括339株来自澳大利亚墨尔本Alfred医院及1343株来自六个公共数据集。
  • 所有分离株均进行全基因组测序和C/T肉汤微量稀释药敏试验,并开展全基因组关联研究和机器学习分析。

主要发现

  • 1682株菌涵盖527个不同序列型,其中343株(20.4%)为C/T耐药,206株(12.2%)检出碳青霉烯酶基因。
  • 既往报道的耐药相关基因(ftsI、mpl、ampD、ampC、ampR和oprD)突变在耐药株中更常见,但也存在于几乎所有敏感株中。
  • 连续突变可导致MIC累加升高,全基因组关联联合机器学习分析先验识别出ftsI、ampR、ampC、PA3329和PA4311五个关键基因与耐药显著相关。
  • 分子对接模拟显示ftsI编码的青霉素结合蛋白3中R504C突变减少与头孢洛扎的结合接触和氢键,显著降低结合亲和力(p 0.016)。

临床怎么用

  • 对C/T耐药铜绿假单胞菌应关注ftsI等基因的连续突变累积,而非单一基因标志。
  • 新发现的PA3329和PA4311基因可作为未来耐药机制研究和检测的候选靶标。

局限性

  • 两个新发现基因PA3329和PA4311的功能尚未确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aimed to conduct a comprehensive genomic analysis of ceftolozane/tazobactam (C/T) resistance mechanisms in Pseudomonas aeruginosa by combining novel institutional data with publicly-available sequencing data. METHODS: We analysed 1682 P. aeruginosa isolates, comprising 339 isolates from Alfred Hospital (Melbourne, Australia) and 1343 isolates from six public datasets. All isolates underwent whole-genome sequencing and C/T broth microdilution susceptibility testing. We assessed previously reported intrinsic and acquired resistance mechanisms. We then conducted a genome-wide association study and machine learning analysis to identify novel genes associated with resistance. We then evaluated the impact of mutations in these genes on MIC values and ceftolozane binding affinity. RESULTS: Among 1682 P. aeruginosa isolates representing 527 distinct sequence types, 343 of 1682 (20.4%) were C/T-resistant. Carbapenemase genes were detected in 206 of 1682 (12.2%) isolates. Mutations in previously reported resistance-associated genes (ftsI, mpl, ampD, ampC, ampR, and oprD) were more frequent in resistant isolates but were also found in almost all susceptible isolates. Successive mutations conferred additive increases in MIC. A combined genome-wide association study and machine learning analyses a priori identified five key genes significantly associated with resistance: ftsI, ampR, ampC, PA3329, and PA4311. Molecular docking simulation revealed that the R504C mutation in penicillin-binding protein 3, which is encoded by ftsI, reduced binding contacts and hydrogen bonds with ceftolozane, significantly decreasing binding affinity (p 0.016). CONCLUSIONS: Our analysis of 1682 P. aeruginosa genomes demonstrated complex pathways to C/T resistance and showed that ftsI may play an underappreciated role. We discovered two previously unidentified genes associated with C/T resistance, whose function remains to be determined.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Nguyen HA, Peleg AY, Song J, et al. Complex pathways to ceftolozane-tazobactam resistance in clinical Pseudomonas aeruginosa isolates: a genomic epidemiology study. Clin Microbiol Infect. 2025. PMID: 41016595. doi:10.1016/j.cmi.2025.09.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。